triazolam has been researched along with Blindness in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Reeth, O | 2 |
| Zhang, Y | 1 |
| Reddy, A | 1 |
| Zee, P | 1 |
| Turek, FW | 2 |
2 other studies available for triazolam and Blindness
| Article | Year |
|---|---|
Aging alters the entraining effects of an activity-inducing stimulus on the circadian clock.
Topics: Aging; Animals; Arousal; Blindness; Circadian Rhythm; Cricetinae; Eye Enucleation; Mesocricetus; Mot | 1993 |
Administering triazolam on a circadian basis entrains the activity rhythm of hamsters.
Topics: Animals; Blindness; Circadian Rhythm; Cricetinae; Male; Mesocricetus; Motor Activity; Triazolam | 1989 |